Page last updated: 2024-08-25

atovaquone and Ocular Toxoplasmosis

atovaquone has been researched along with Ocular Toxoplasmosis in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (41.67)18.2507
2000's3 (25.00)29.6817
2010's4 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chorlton, SD1
Fekrat, S; Proia, AD; Rao, V; Schneider, E1
Crutchley, C; Dubey, JP1
Androudi, S; Bhaila, I; Fiore, T; Iaccheri, B; Janjua, S; Papadaki, T; Stephen Foster, C1
Godehardt, E; Joussen, AM; Maier, AK; Severing, K; Stammen, J; Winterhalter, S1
Freund, KB; Holland, GN; Kreiger, AE; Nguyen, QD; Vance, SK; Wenick, AS1
Baatz, H; Gümbel, H; Hattenbach, LO; Mirshahi, A; Puchta, J1
Althaus, C; Armbrecht, C; Jablonowski, H; Schimkat, M; Sundmacher, R1
Althaus, C; Hudde, T; Schimkat, M; Sundmacher, R1
Gormley, PD; Lightman, S; Minnasian, D; Pavesio, CE1
Jaffe, GJ; Pearson, PA; Piracha, AR; Sen, HA1
de Smet, MD; Lopez, JS; Masur, H; Mueller, BU; Nussenblatt, RB; Pizzo, PA1

Trials

2 trial(s) available for atovaquone and Ocular Toxoplasmosis

ArticleYear
Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2010, Volume: 248, Issue:8

    Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Secondary Prevention; Toxoplasmosis, Ocular; Visual Acuity; Young Adult

2010
Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients.
    Ophthalmology, 1999, Volume: 106, Issue:1

    Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Drug Evaluation; Female; Follow-Up Studies; Fundus Oculi; Humans; Immunocompetence; Middle Aged; Naphthoquinones; Prospective Studies; Safety; Toxoplasmosis, Ocular; Treatment Outcome; Visual Acuity

1999

Other Studies

10 other study(ies) available for atovaquone and Ocular Toxoplasmosis

ArticleYear
Adjunctive bradyzoite-directed therapy for reducing complications of congenital toxoplasmosis.
    Medical hypotheses, 2019, Volume: 133

    Topics: Animals; Antiprotozoal Agents; Atovaquone; Brain; Chorioretinitis; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eye; Humans; Infant; Infant, Newborn; Mice; Models, Biological; Recurrence; Spiramycin; Toxoplasma; Toxoplasmosis, Animal; Toxoplasmosis, Cerebral; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular

2019
Development of bilateral acquired toxoplasmic retinochoroiditis during erlotinib therapy.
    JAMA ophthalmology, 2014, Volume: 132, Issue:9

    Topics: Adenocarcinoma; Anti-Infective Agents; Atovaquone; Chorioretinitis; ErbB Receptors; Erlotinib Hydrochloride; Female; Food Parasitology; Humans; Lung Neoplasms; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Toxoplasma; Toxoplasmosis, Ocular

2014
Toxoplasmosis in wallabies (Macropus rufogriseus and Macropus eugenii): blindness, treatment with atovaquone, and isolation of Toxoplasma gondii.
    The Journal of parasitology, 2008, Volume: 94, Issue:4

    Topics: Animals; Anti-Infective Agents; Atovaquone; Biological Assay; Cats; Female; Macropodidae; Male; Mice; Toxoplasma; Toxoplasmosis, Animal; Toxoplasmosis, Ocular

2008
Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
    Clinical therapeutics, 2008, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Atovaquone; Clindamycin; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Exanthema; Female; Gastrointestinal Diseases; Humans; Male; Medical Records; Middle Aged; Pyrimethamine; Retrospective Studies; Sulfadiazine; Sulfamethoxazole; Toxoplasmosis, Ocular; Trimethoprim; Vitreous Body; Young Adult

2008
Diagnostic and therapeutic challenges.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:6

    Topics: Adult; Anti-Infective Agents; Atovaquone; Chorioretinitis; Diagnosis, Differential; Eye Diseases; Female; Fluorescein Angiography; Humans; Recurrence; Tomography, Optical Coherence; Toxoplasmosis, Ocular; Visual Acuity; Vitreous Body

2011
Reactivation of toxoplasma retinochoroiditis under atovaquone therapy in an immunocompetent patient.
    Ocular immunology and inflammation, 2006, Volume: 14, Issue:3

    Topics: Adult; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Drug Resistance, Microbial; Female; Humans; Immunocompetence; Naphthoquinones; Oxidoreductases; Recurrence; Toxoplasma; Toxoplasmosis, Ocular; Visual Acuity

2006
[Treatment of toxoplasmosis retinochoroiditis with atovaquone in an AIDS patient].
    Klinische Monatsblatter fur Augenheilkunde, 1995, Volume: 206, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorescein Angiography; Follow-Up Studies; Humans; Male; Middle Aged; Naphthoquinones; Toxoplasmosis, Ocular

1995
[Treatment of toxoplasmosis retinochoroiditis with atovaquone in an immunocompetent patient].
    Klinische Monatsblatter fur Augenheilkunde, 1996, Volume: 209, Issue:4

    Topics: Adult; Animals; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Female; Follow-Up Studies; Humans; Male; Naphthoquinones; Recurrence; Toxoplasma; Toxoplasmosis, Ocular

1996
Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease.
    Investigative ophthalmology & visual science, 1998, Volume: 39, Issue:7

    Topics: Acute Disease; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Atovaquone; Brain; Chorioretinitis; Chronic Disease; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Female; Mesocricetus; Naphthoquinones; Retina; Toxoplasma; Toxoplasmosis, Cerebral; Toxoplasmosis, Ocular

1998
Orally administered 566C80 for treatment of ocular toxoplasmosis in a patient with the acquired immunodeficiency syndrome.
    American journal of ophthalmology, 1992, Mar-15, Volume: 113, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Antiprotozoal Agents; Atovaquone; Eye Infections, Parasitic; Follow-Up Studies; Fundus Oculi; Humans; Male; Naphthoquinones; Toxoplasmosis, Ocular

1992